There’s a laundry list of things they have to do before they can even think about up listing, I’m sure the doc has a plan but it’ll take time.

look at the NASDAQ rules to up list, it’s not exactly an easy thing to do. That’s why I’m saying it’ll take a year.

Uplisting is at a minimum a year out. It’ll probably happen shortly after market approval.

Two things that will cause the FDA to respond earlier than the 30 days or they should respond earlier.

The company took the EFS IDE path, which if you don’t know what that is, it means that the FDA held the company’s hand and they told exactly what testing that they wanted done and the FDA set the parameters for all of the tests as well.

2. They have the BDD designation which is supposed to expedite reviews.

I’m more on the 10 to 15 days they will have a response. My opinion of course

No news in the otc is a death sentence for a stock, and it doesn’t matter what catalyst is coming, until a PR drops or traders feel that it’s getting closer for the PR to drop, they will trade elsewhere.


Until the company starts dropping PRs to get more and new traders coming the MMs control this.

Until the Outstanding Shares change there’s no dilution going on now. The shares are accounted for.

There’s no dilution going on. The shares from the offering have been accounted for weeks ago. OS hasn’t moved in weeks.

When the sell of the offering is finalized the company gets the money right away.

Now in some offerings there can be restrictions on when they can and how much they can sell. What I get from this is that they have no restrictions. The shares were accounted for right away. Now those buyers of the offering essentially can hold or sale whenever they want, those buyers of the offering know exactly what’s coming and majority of them more than likely are holding their shares until the idea submittal and possibly even longer.

No dilution is going on

Yep, they obviously don’t know anything about the company and what’s at stake here.

This still has good chance of getting to around.30-.40 before submission.

I hope he has his sell order in already, he’s going to miss out on a run of a lifetime.

All the shares from the offering are accounted for in OS already, there is no more dilution

Share price is going down because there’s no news and volume is weak so now the MMs will control it for now.

A true narcissist

I know right. Some on this board would prefer the personal to sit around on their asses and put out bs updates just to make them happy.

Exactly

I’m guessing we will get word 10-15 days after submitting.

We did the EFS IDE route and we have the BDD, not quite sure the bdd will help speed up the review or not.

Time will tell, I’m guessing end of next week the earliest the latest would be around the 10/11th of June

Correct, there’s been no news so what happens to an otc ticker when there’s no news the MMs will take control and start dropping the price.

There’s probably been a little selling of the offering but there’s still a lot out there

You would have to reach out to the company. And then they would give you the information of who to contact to actually buy the offering. They rarely just let anyone buy the offerings.

Right now the offering is closed as far as I know.

They will probably have another offering towards the end of the 4th quarter depending on how much cash they will need for the following year.

Expect that offering to be a lot higher but still probably around a 20-30 percent discount of whatever the current share price is. Also there’s usually a minimum you have to buy. Most offerings usually come with stipulations like how long you have to hold before you can sell them for and how many shares you can sell at one time.

But if they allow you to buy the brokerage firm in charge of the offering will give you all the details.

I highly doubt very many shares of the offering has been sold.

The individuals and institutions that bought the offering know exactly what’s coming and what will happen when the idea is submitted.

They got a hell of a break on cost and why sell for a lousy double maybe triple their cost when they can make at minimum 10x more than what they paid for them.

If it was me, I would sell enough on the submittal to get my money back and then hold on to the rest.

Anyone can see how many shares of the offering is left by going to the SEC website.

As of last week there was some 34 million shares left.

I believe a few are on Reddit

If you haven’t already, I suggest getting on the. Company website and select getting updates directly from the company by email, these updates are supposed to get to you before they announce them.

They put one out yesterday, saying that the IDE will be submitted before the end of June and that they will start putting weekly updates on their website.

When you do this check your spam folder that’s where mine was.

But but but I’m an investor and I deserve daily updates.
No wait i demand daily updates.

Welcome to the OTC bitches be happy with what you get.

Please in detail explain to me how they can expand and push on vivos when vivos has not been approved for human use as of yet.

Please explain in detail how they push the process for vivos, when all testing is outsourced.

Please in detail how a start up company in the OTC is going to be more involved in pushing the testing and review process.

Please in details how this company can do that.


There’s no pushing vivos, the big pharma don’t want it, they love chemo it’s their bread winner.


So please for the love of god in detail what can they do.

Push the FDA, that would be an absolutely horrendous idea, as a company you don’t push the FDA.


Again you keep saying that they need to be pushing the ide.

How in the fuck can they do that.

Again all the testing is outsourced, pearl is a 3rd party company doing the review of the vx2 study that was requested by the FDA.

So again in detail please explain how the company can push these test results and the review by a 3rd party.


You have been bitching about this for years so now I’m calling your ass out.

In detail how do you fast track all this.

Well said

You are right you can ask all the questions you want but asking a IHUB board why the company doesn’t communicate better is well just dumb on your part. And especially asking this about a startup company in the OTC, thank god you weren’t here when the doctor first took over, it would be months before we got any kind of update.

The doctor will never give out updates on the ide process until he’s 100 percent ready to. So get over it and Just deal with it.

You should be asking those questions directly to the company, I’ll save you time and this is what they will tell you, the same thing that they have been telling everyone.

They are on track with the review process.

They gave a timeline for submitting the ide 2nd quarter. What more do you want.

Even If they told us every time that they got done reviewing a section all people will do is still ask what’s taking so long, why can’t they give us a exact date, they should be submitting by now.


You are lucky that they even give us that much information.

You Already answered your own question as well, we are in the OTC and not one penny/sub penny play has ever been straight forward with information. So why would you expect this company to be any different.

They have made major strides over the last few years and getting better at getting information out, but it’s just a start up company with a tight budget, so there updates come by Facebook and X.

Official PRs and articles cost money. Which the investor you are should know that by now.

If you want consistent updates and the ones you want, you have the wrong company

Well if you would pay attention.

They have posted on twitter several times stating that the review process is on track.

So don’t expect anything more than that.

Your question has been answered many times over.

Testing takes time and the tests they had to run you don’t rush through.

All testing was outsourced to University of Missouri Vet, Johns Hopkins vet.

No testing was done in house.

You obviously have zero knowledge and understanding whatsoever in what it takes to perform these tasks.

The lab technicians/doctors will not rush these tests.

Going through the data and information is something you don’t rush through.

The FDA is going through this information and the VIVOS has to have everything in order.

Why work on pushing isopet, why not they weren’t doing a whole lot while they were waiting for the tests to be done.

I’d rather have them working on something instead of nothing at all while waiting

Lab techs/scientists that are doing the tests and reviewing are extremely cautious when it comes to giving exact dates. They will go through the information a few times if not more to make sure everything looks. So giving an exact date of completion will put even more pressure on them, not like they have any pressure on them already.

They screw up, they can’t just fix the issue when the FDA finds it and they can continue forward, The FDA finds something wrong there’s no second chances, the IDE fails and the company has to start all over.

The FDA is going to go through this application with a fine tooth comb and will dissect every piece of data

Exactly what kind of updates are you looking for.

Pearl is reviewing the VX2 rabbit study
The radiogel team is reviewing everything else
The Mayo clinic is trained and ready to go.

Don’t believe that they can give anymore updates than that.

They won’t give an exact date of submittal until they are 100 percent ready. The doc extremely conservative about this.

If they put an exact date and missed it, it would hurt the share price big time, even if it was by 1 day. This would put major concern into investors thoughts.

So since they won’t release anything about the IDE until they are ready. They are moving forward with isopet

The company has to be extremely cautious when releasing any information about EFS IDE process.

Not hard to understand. Frustrating for the ones that only care about the IDE.

On point my ass. About the only thing you might be right is the few bitching about the price drop and that it might cost the company to get a clinic certified to use isopet.

By chance have you actually asked the company about how much it costs the company to certify a clinic.

As for the drop in price you are completely wrong that is dilution. Majority of those shares the buyers of the Reg. A, Majority of those buyers still have majority if not all of their shares.

The Reg. A buyers know exactly what they own and got shares at a discounted price. Why would they sell when they know what’s getting ready to happen.

So there’s a good reason why this post is getting deleted. You are wrong

Price drop is because of no news so then gives MMs free rein and the shorts can jump in as well.

You can look the share count in the SEC

So you are going on opinion only,

Yes I would take the treatment and yes I would tell everyone else I know.


Early management was a joke and was using the company to cash in.

Very little testing was done back then.

If you would have actually stuck around DR. K has done extensive testing and has documentation that the Y90 is contained in the tumor.

The books are clean and share structure is pretty good for an OTC.

Oh yeah and Mayo Clinic is on board and John’s Hopkins vet did all the rabbit testing.


But you know everything based on your opinion and a timeline. Good luck to you and do us a favor stay away this time

What documents do you have to prove that the Y90 leaks into the bloodstream.

lol a reverse split, come on that’s what you’re thinking.

They are no where close to even think about a reverse split.

And no one cares if you were around when moose got his treatment and if you sent recipes to a site.

Pathetic

Well you’re definitely know a lot more than most new and long holders here.

You obviously know what you own and know how big this will get in the very near future.

Then you should sell now, did you actually read the article.

I agree with you on that. In few weeks time everyone’s anxiety, depression and disappointment will finally will be over.

Anyone that has higher blood pressure better makes sure they have their meds full when this starts to fly, they will definitely need it. I’ll be taking the day off of work.

I’m hoping you’re right and kinda agree with you,

I’m thinking possibly another day of bs then possibly late Friday the reversal will happen. Worse case scenario probably won’t happen until late next week with new traders jumping in thinking the submittal PR will drop first week in June.

I agree completely. But unfortunately they won’t stop complaining

I’d rather see this offering done now and see the dilution before this starts running off real news.

Dilution of any kind can put the brakes on run. I’ve seen it happen and pretty sure others have as well.

Would you rather have it happen around .20 or when this has the potential to run to $2 plus dollars or more.

This is the otc and anything that you can think of good or bad it can happen here.

Yep and don’t give a shit, nice that you can point it out.

Boo hoo

I can chastise whoever the hell i want, you don’t like it, quit ball bagging, no one likes a whiner. Or block me. I’m sure in hell ain’t going to lose any sleep over it.

Then quit your bitching, no one gives a shit how many times you didn’t sell and make money. Bitch to someone who actually cares.

Buddy I’ve been here a very long time and I know the frustration, but keep the whining to yourself.

No I won’t grow up. I can’t stand people that whine, they are weak and pathetic

Once human trials start, that’s all on the Mayo Clinic.

As for the rest of their plans that is on radiogel. So we will see.

Which this should not be a problem for the company to concentrate and push forward with everything else since they really won’t have much to do with the human trials.

Bye bye no one cares